Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 17c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.88), $0.17 worse than the analyst estimate of ($0.71).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KeyBanc Upgrades Nucor (NUE) to Overweight
• MSCI acquires First Street for $120M to expand climate risk data